415 related articles for article (PubMed ID: 31522431)
1. The Toll-like Receptor 2 (TLR2)-related Immunopathological Responses in the Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Jafarzadeh A; Nemati M; Khorramdelazad H; Mirshafiey A
Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):230-250. PubMed ID: 31522431
[TBL] [Abstract][Full Text] [Related]
2. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
[TBL] [Abstract][Full Text] [Related]
3. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.
Shen ZY; Zheng Y; Pecsok MK; Wang K; Li W; Gong MJ; Wu F; Zhang L
Front Immunol; 2021; 12():589200. PubMed ID: 33841391
[TBL] [Abstract][Full Text] [Related]
4. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
Lee SY; Goverman JM
J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
[TBL] [Abstract][Full Text] [Related]
5. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS.
Zekki H; Feinstein DL; Rivest S
Brain Pathol; 2002 Jul; 12(3):308-19. PubMed ID: 12146799
[TBL] [Abstract][Full Text] [Related]
6. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
Batoulis H; Addicks K; Kuerten S
Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
[TBL] [Abstract][Full Text] [Related]
7. Th9 cells in the pathogenesis of EAE and multiple sclerosis.
Elyaman W; Khoury SJ
Semin Immunopathol; 2017 Jan; 39(1):79-87. PubMed ID: 27844107
[TBL] [Abstract][Full Text] [Related]
8. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
9. Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis.
Li X; Zhao L; Han JJ; Zhang F; Liu S; Zhu L; Wang ZZ; Zhang GX; Zhang Y
Front Immunol; 2018; 9():1807. PubMed ID: 30150982
[TBL] [Abstract][Full Text] [Related]
10. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
Luz A; Fainstein N; Einstein O; Ben-Hur T
Exp Neurol; 2015 Nov; 273():234-42. PubMed ID: 26342755
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
[TBL] [Abstract][Full Text] [Related]
12. Systemic TLR2 tolerance enhances central nervous system remyelination.
Wasko NJ; Kulak MH; Paul D; Nicaise AM; Yeung ST; Nichols FC; Khanna KM; Crocker S; Pachter JS; Clark RB
J Neuroinflammation; 2019 Jul; 16(1):158. PubMed ID: 31351476
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation.
Horiuchi H; Parajuli B; Komiya H; Ogawa Y; Jin S; Takahashi K; Azuma YT; Tanaka F; Suzumura A; Takeuchi H
Front Immunol; 2021; 12():615898. PubMed ID: 33776998
[TBL] [Abstract][Full Text] [Related]
15. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
16. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
17. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
18. Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Gao H; Danzi MC; Choi CS; Taherian M; Dalby-Hansen C; Ellman DG; Madsen PM; Bixby JL; Lemmon VP; Lambertsen KL; Brambilla R
Cell Rep; 2017 Jan; 18(1):198-212. PubMed ID: 28052249
[TBL] [Abstract][Full Text] [Related]
19. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
20. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
Spanier JA; Nashold FE; Olson JK; Hayes CE
J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
